Attenuated oncolytic measles virus as a new therapeutic approach against pediatric acute lymphoblastic leukemia : a proof of principle
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Ulm, Universität Ulm, Dissertation, 2018
- Schlagwort
-
Akute lymphatische Leukämie
Kind
Onkologie
Masernvirus
- DOI
-
10.18725/OPARU-6216
- URN
-
urn:nbn:de:bsz:289-oparu-6273-1
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zirngibl, Felix
- Universität Ulm
Entstanden
- 2018
Ähnliche Objekte (12)
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle